Abbott Laboratories (ABT)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 13,599,000 | 14,522,000 | 17,296,000 | 18,527,000 | 16,661,000 |
| Total assets | US$ in thousands | 73,214,000 | 74,438,000 | 75,196,000 | 72,548,000 | 67,887,000 |
| Debt-to-assets ratio | 0.19 | 0.20 | 0.23 | 0.26 | 0.25 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $13,599,000K ÷ $73,214,000K
= 0.19
Abbott Laboratories' debt-to-assets ratio has been showing a decreasing trend over the past five years, indicating a positive sign as it means the company is relying less on debt to finance its operations and investments. As of December 31, 2023, the debt-to-assets ratio stands at 0.20, down from 0.23 in the previous year and 0.27 in 2019. This suggests that Abbott Laboratories has been effectively managing its debt levels relative to its total assets, which is favorable for investors and creditors. The decreasing trend in the debt-to-assets ratio reflects a stronger financial position and lower financial risk for the company.
Peer comparison
Dec 31, 2023